Greenblatt influences drug safety policy at Duke and statewide

Greenblatt

Lawrence Greenblatt, MD

Larry Greenblatt, MD, Duke Associate Professor of Medicine, demonstrates the impact possible as a clinician-educator in the academic medical center.

In Singapore, Duke-NUS, he continues to teach medical students and to provide education for medicine residents so that they can more effectively teach (take a look at this previous post).

Dr. Greenblatt has been doing interesting work about improving Opioid Safety, both locally within Duke Health and statewide within North Carolina. His background includes a number of years working with Northern Piedmont Community Care (NPCC), currently as the Medical Director. NPCC provides practice support, care management, and population management primarily for Medicaid recipients.

Duke Opioid Task Force

Larry is co-leader of the Duke Opioid Safety Task Force. This group is a unique effort to change the health system and the way we manage opioid prescriptions. Duke Health is close to final approval of a tool within Maestro, our electronic medical record, launching a template that aids clinicians in confirming adherence to opioid prescribing guidelines. This tool will provide feedback, report the percent adoption, and set a quality standard metric. The Task Force intends to set up required CME for clinicians prescribing opioids. Altogether this is an example of an important administrative step towards improving care of patients.

NC Medical Board

All of this experience has placed Dr. Greenblatt in position to be asked to serve in an advisory role for a committee of the NC Medical Board. The Board historically has a mission for licensing and investigation of complaints about patient care. This time the Board has taken responsibility for monitoring clinical practice and Dr. Greenblatt’s expertise was solicited.

NC Medicaid Pharmacy and Therapeutics Committee

Dr. Greenblatt took over this month as the Chair of the NC Medicaid Pharmacy and Therapeutics committee. This program offers a comprehensive prescription drug benefit, ensuring that low-income North Carolinians have access to the medicine they need.

Congratulations, Dr. Greenblatt. Thank you for sharing your expertise and representing Duke General Internal Medicine.

 

Leave a Reply

Your email address will not be published.